You have read all your free articles, to continue reading subscribe to read the rest of this content.
Xbrane Biopharma's efforts to divest the subsidiary Primm Pharma continues although negotiations with the previously expected acquirer NewFaDem for the time being has been paused. Primm Pharma is a fully owned subsidiary of Xbrane specialized in long-acting injectables and developer of SpherotideAlready a subscriber Login You have read all your…
Swiss Roche has announced that the company has agreed to acquire Danish biopharmaceutical firm Santaris Pharma for USD 450 million. The plan is to expand discovery and development of RNA-targeting medicines. Santaris Pharma has pioneered its proprietary Locked Nucleic Acid (LNA) platform that haAlready a subscriber Login You have read all…
Mesa Laboratories has announced the acquisition of Gyros Protein Technologies Holding AB. GPT is headquartered in Uppsala, Sweden and the acquisition deepens Mesa's commitment to biopharmaceutical quality control and will be the core of its new platform, Biopharmaceutical Development, it states. Already a subscriber Login You have read all your…
The global pharmaceutical company Organon is acquiring its portfolio company Forendo Pharma. Forendo Pharma's shareholders will receive an initial payment of USD 75 million and are entitled to additional future payments totaling USD 870 million upon the achievement of certain development, registrAlready a subscriber Login You have read all your…
